Evaluating the Use of Biosimilars for Rheumatologic Conditions

This program, featuring on-demand audio from an expert-led Webinar, downloadable slides, and 2 ClinicalThought commentaries, explores the regulatory approval pathways for biosimilars used in rheumatologic conditions as well as how they differ from their reference biologics and small molecule generics and their place in therapy.
Beth L. Jonas, MD
William F. C. Rigby, MD

On-Demand Webcast

Listen to this downloadable audio from a live Webinar in which a rheumatology expert discusses the complexities of developing biosimilar products and making them available for patients with rheumatologic conditions.

Released: July 19, 2017

Downloadable Slideset

In this downloadable slideset, William F. C. Rigby, MD, and Beth L. Jonas, MD, review key data to enhance your understanding of biosimilars and their clinical application to rheumatologic conditions.

Released: July 18, 2017

ClinicalThought

What does the availability of biosimilar products mean in your approach to rheumatologic conditions?

William F. C. Rigby, MD Released: June 12, 2017

What should you tell your rheumatology patients about biosimilars?

Beth L. Jonas, MD Released: July 18, 2017
Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC.
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com

Supported by an independent medical education grant from
Sandoz Inc., a Novartis Division

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?